Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Gypsy retrotransposon integrase 1 (GIN1) is a protein-coding gene derived by molecular domestication from ancestral Gypsy/Ty3/Gypsy LTR retrotransposon integrases and is present in mammals, birds, and reptiles[2][3]. GIN1 contains a conserved HHCC zinc finger domain, suggesting possible nucleic acid binding capabilities, and shares some key residues with retrotransposon integrases, though its integrase catalytic activity in vertebrates is not established[2][3]. Its biological role in vertebrates remains unknown, and there are no current data linking GIN1 to specific diseases or therapeutic applications; it is not a recognized therapeutic target[2][3].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Gypsy retrotransposon integrase 1 (GIN1).